|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000125834 |
Summary for STK35 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000125834 | Gene symbol | STK35 |
| Gene name | serine/threonine kinase 35 | |
| HGNC | 16254 | |
| Entrez ID | 140901 | |
| Gene type | protein_coding | |
| Synonyms | STK35|bA550O8.2|CLIK1 | |
| UniProtAcc | Q8TDR2 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000125834 | STK35 | DB12010 | Fostamatinib | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for STK35 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| STK35 | 1.45e+03 | 1.13e+00 | 2.36e-01 | 4.78e+00 | 1.74e-06 | 1.19e-05 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for STK35 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for STK35 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for STK35 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for STK35 |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| LUAD | STK35-003 | chr20_2147823_+ | 1.49e-01 | 1.72e-01 | -2.72e+00 | 6.56e-03 | 2.42e-02 | -2.31e-02 |
| COAD | STK35-003 | chr20_2131197_+ | 6.67e-01 | 3.73e-01 | 2.74e+00 | 6.17e-03 | 1.72e-02 | 2.94e-01 |
| PAAD | STK35-003 | chr20_2147823_+ | 1.56e-01 | 1.27e-01 | 2.24e+00 | 2.53e-02 | 4.66e-02 | 2.88e-02 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| LUAD | STK35-003 | chr20_2147823_+ | 1.72e-01 | 1.19e-01 | 2.91e+00 | 3.57e-03 | 9.15e-03 | 5.28e-02 |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for STK35 |
TFs related to STK35.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BLCA | SP1 | STK35 | 4.18e+00 | 9.84e-01 | 3.12e+00 | 3.99e-03 | Male-biased |
| BLCA | ZNF180 | STK35 | 4.22e+00 | 9.85e-01 | 3.15e+00 | 3.86e-03 | Male-biased |
| BLCA | ZNF30 | STK35 | 4.27e+00 | 9.84e-01 | 3.36e+00 | 6.56e-03 | Male-biased |
| BLCA | ZNF519 | STK35 | 4.13e+00 | 9.81e-01 | 3.21e+00 | 6.36e-03 | Male-biased |
| BLCA | ZNF571 | STK35 | 4.22e+00 | 9.83e-01 | 3.29e+00 | 6.10e-03 | Male-biased |
| ESCA | ELK4 | STK35 | 3.56e+00 | 8.54e-03 | 4.39e+00 | 9.86e-01 | Female-biased |
| ESCA | GABPA | STK35 | 3.41e+00 | 3.66e-03 | 4.43e+00 | 9.91e-01 | Female-biased |
| ESCA | ZNF200 | STK35 | 3.68e+00 | 5.82e-03 | 4.60e+00 | 9.90e-01 | Female-biased |
| ESCA | ZNF519 | STK35 | 3.10e+00 | 6.41e-03 | 3.99e+00 | 9.83e-01 | Female-biased |
| ESCA | ZNF571 | STK35 | 3.08e+00 | 4.17e-03 | 4.06e+00 | 9.86e-01 | Female-biased |
| ESCA | ZNF770 | STK35 | 3.05e+00 | 5.61e-03 | 3.96e+00 | 9.83e-01 | Female-biased |
STK35 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for STK35 |
RBPs related to ES in STK35.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | KHDRBS1 | exon_skip_348451 | 6.61e+00 | 9.81e-01 | 6.08e+00 | 2.25e-03 | Male-biased |
STK35 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs3897510 | chr20:6148621:A:C | - | 0.0615591947191688 | 0.0429744674575658 | LGG | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs6053807 | chr20:667787:T:G | - | 0.0731605202580828 | 0.0295680918718735 | STAD | Male-baised eQTL |
| rs226186 | chr20:9000994:G:T | - | -0.0606803030109639 | 0.0224214118805951 | LUAD | Male-baised eQTL |
| rs6033860 | chr20:1467930:A:G | - | 0.0525739294982706 | 0.014402660089602 | COAD | Male-baised eQTL |
| rs6055590 | chr20:8169761:G:T | - | 0.056685877597332 | 0.0155018707188432 | COAD | Male-baised eQTL |
| rs7272428 | chr20:680009:A:T | - | 0.0529582180251845 | 0.0223799307961819 | COAD | Male-baised eQTL |
| rs2423521 | chr20:10811851:T:G | - | 0.0540827624355442 | 0.0335724548204424 | COAD | Male-baised eQTL |
| rs926815 | chr20:8147935:C:T | - | 0.0625361691740666 | 0.0391259513070642 | COAD | Male-baised eQTL |
| rs6033024 | chr20:1178828:T:C | - | -0.0493378657319156 | 0.041189057479606 | COAD | Male-baised eQTL |
| rs2423524 | chr20:10817032:A:C | - | 0.0514969277200556 | 0.0493530438844063 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg12237948 | chr20:2104511 | gene,enhancer | -0.406208036496254 | 1.39766924906357e-13 | -0.45443152776322093 | 4.964185050206803e-16 | LGG |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg10206397 | chr20:2104698 | gene,enhancer | -0.379801244275305 | 1.32213030741144e-05 | -0.5939780455159976 | 3.036167057500846e-08 | KIRP |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of STK35 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |